IONQ
IONQ
$44.86
+8.02%
IonQ, Inc. is a technology company that provides access to quantum computers via cloud platforms and its own cloud service, offering quantum-computing-as-a-service (QCaaS) along with consulting and specialized system contracts. As a pure-play leader in the quantum computing industry, IonQ is distinguished by its trapped-ion technology and early-mover advantage in commercializing quantum solutions. The current investor narrative centers on the company's explosive revenue growth and government support, but is tempered by persistent losses, insider selling, and the need for substantial capital to fund R&D and achieve long-term viability. Recent headlines highlight both the potential of quantum computing and the high-risk, high-reward nature of the stock, with a 40% drawdown from all-time highs sparking debate on valuation and execution risks.…
IONQ
IONQ
$44.86
Related headlines
Investment Opinion: Should I buy IONQ Today?
Rating & Thesis: I rate IONQ as a Hold. While the company is a leader in quantum computing with explosive revenue growth, the extreme valuation and persistent losses make it a high-risk investment. The analyst consensus is Strong Buy with an average target of $67.68, implying 50.9% upside, but this optimism is tempered by the fundamental challenges.
Sign up to view all
IONQ 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While IonQ's growth potential is significant, the deceleration in revenue growth and deep losses create uncertainty. The stock's valuation, though lower than historical peaks, remains extremely high, and the market's expectations may be too optimistic. If revenue growth re-accelerates and margins improve, the stance could upgrade to bullish. Conversely, if cash burn worsens or growth stalls, a downgrade to bearish is warranted.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $67.68 and implied upside of +50.9% versus the current price.
Average Target
$67.68
0 analysts
Implied Upside
+50.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $100
Analyst target range
IonQ is covered by 13 analysts, with a consensus recommendation of 'Strong Buy' and a mean rating of 1.38 (where 1 is Strong Buy). The average target price is $67.68, implying an upside of +50.9% from the current price of $44.86. The target range is wide, from a low of $44.78 (essentially at current price) to a high of $100.00, indicating significant uncertainty about the company's future. The high target assumes continued rapid growth and successful commercialization, while the low target reflects concerns about cash burn and execution risks. Recent analyst actions have been mostly positive, with firms like Benchmark and Needham maintaining Buy ratings, but there are no recent downgrades. The wide spread in targets suggests that while the consensus is bullish, there is considerable risk, and investors should weigh the potential upside against the high volatility and fundamental challenges.
Bulls vs Bears: IONQ Investment Factors
IonQ presents a classic high-risk, high-reward profile. The bull case rests on explosive revenue growth, strong analyst support, and a solid balance sheet, while the bear case highlights deep losses, decelerating growth, extreme valuation, and insider selling. Currently, the bearish evidence is stronger due to the unsustainable cash burn and the massive gap between valuation and fundamentals. The single most important tension is whether IonQ can achieve the scale and profitability to justify its 96.75x PS ratio, or if the growth slowdown and cash burn will force a dramatic de-rating. The outcome of this tension will determine whether the stock is a speculative gem or a value trap.
Bullish
- Explosive Revenue Growth: IonQ's revenue surged from $7.57M in Q1 2025 to $64.67M in Q1 2026, a 755% YoY increase. This demonstrates rapid commercial adoption of its quantum computing services, outpacing most tech companies.
- Strong Analyst Consensus: With a Strong Buy rating (mean 1.38) and an average price target of $67.68, analysts see 50.9% upside from the current price of $44.86. The high target of $100 implies a potential 123% gain.
- Robust Balance Sheet: IonQ holds a current ratio of 15.5 and minimal debt (debt-to-equity of 0.79%), providing ample liquidity to fund R&D and operations without immediate solvency risk.
- Government Support: Recent news highlights Washington's quantum push, with direct equity ownership creating a sovereign-backed capital runway for domestic leaders like IonQ, reducing funding uncertainty.
Bearish
- Deep Operating Losses: IonQ reported an operating loss of $271.5M in Q1 2026, with operating margin at -419.8%. The company is far from profitability, burning cash at an unsustainable rate.
- Decelerating Growth: Revenue growth slowed to 7.55% YoY in Q1 2026, a sharp deceleration from the 212% YoY growth in Q2 2025. This raises questions about the sustainability of its growth trajectory.
- Extreme Valuation: At 96.75x trailing PS and 55.87x EV/Sales, IonQ trades at a massive premium to any reasonable fundamental benchmark. Even with high growth, the stock must deliver exceptional results to justify this price.
- Massive Cash Burn: Free cash flow was -$424.76M over the trailing twelve months, requiring continuous external financing. This has led to significant dilution, with shares outstanding rising from 228.8M in Q1 2025 to 358.8M in Q1 2026.
IONQ Technical Analysis
IonQ's stock has exhibited a volatile uptrend over the past year, with a 1-year price change of +20.69%, though it has experienced significant swings. The current price of $44.86 sits at 32.6% of its 52-week range (between $25.89 and $84.64), indicating a substantial pullback from the highs. This positioning suggests the stock is in a corrective phase after a strong rally, with the potential for value accumulation but also risk of further downside if support fails. The 6-month price change of +40.63% reflects a strong recovery from the lows, but the stock remains well below its peak, highlighting the market's uncertainty about the company's near-term prospects.
Beta
3.30
3.30x market volatility
Max Drawdown
-67.6%
Largest decline past year
52-Week Range
$26-$85
Price range past year
Annual Return
+20.7%
Cumulative gain past year
| Period | IONQ Return | S&P 500 |
|---|---|---|
| 1m | +29.4% | +3.6% |
| 3m | -29.5% | +2.7% |
| 6m | +40.6% | +11.4% |
| 1y | +20.7% | +18.7% |
| ytd | -4.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IONQ Fundamental Analysis
IonQ's revenue has grown rapidly, with the most recent quarter (Q1 2026) reporting revenue of $64.67 million, a YoY growth of 7.55% from the prior year quarter. However, this growth rate is a deceleration from the explosive triple-digit growth seen in earlier quarters (e.g., Q2 2025 revenue was $20.69 million, implying a 212% YoY increase). The company's revenue trajectory is still expanding, but the pace is slowing, which may raise concerns about sustainability. The gross margin in Q1 2026 was 23.84%, down from 56.48% in Q4 2025, indicating margin compression due to higher costs and product mix shifts. IonQ reported a net income of $805.36 million in Q1 2026, but this was driven by a one-time gain from a change in fair value of warrant liabilities (total other income of $1.07 billion), not core operations. Excluding this, the company is deeply unprofitable, with an operating loss of $271.51 million and a net margin of 12.45% (inflated by the non-cash gain). The company's balance sheet is strong with a current ratio of 15.50 and minimal debt (debt-to-equity of 0.79%), but it is burning cash, with free cash flow of -$424.76 million over the trailing twelve months. This indicates reliance on external financing, as evidenced by significant equity raises in recent quarters, which dilutes shareholders.
Quarterly Revenue
$64668000.0B
2026-03
Revenue YoY Growth
+754.7%
YoY Comparison
Gross Margin
23.8%
Latest Quarter
Free Cash Flow
$-424755000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IONQ Overvalued?
Given IonQ's negative net income and EBITDA, the appropriate valuation metric is the price-to-sales (PS) ratio, which stands at 96.75x trailing and 55.87x EV/Sales. This is extremely high, reflecting the market's pricing of future growth potential. The forward PE is -36.93x, but since earnings are negative, the PS ratio is more meaningful. Compared to the industry average (if available), IonQ trades at a significant premium, but the data does not provide industry averages. Historically, IonQ's PS ratio has ranged from 127x to 8591x over the past five years, with the current 96.75x near the lower end of that range, suggesting a relative de-rating. This could indicate that the market is becoming more cautious about the company's ability to grow into its valuation, or it could represent a value opportunity if growth accelerates.
PE
-24.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-24.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IonQ's most pressing financial risk is its cash burn. With free cash flow of -$424.76M over the trailing twelve months and an operating loss of $271.5M in Q1 2026, the company relies heavily on external financing. While the current ratio of 15.5 provides short-term liquidity, the need for continuous capital raises dilutes shareholders, as evidenced by the 57% increase in shares outstanding over the past year. Additionally, gross margin compression from 56.48% in Q4 2025 to 23.84% in Q1 2026 signals operational inefficiencies and product mix shifts that could pressure future profitability. Revenue concentration in a nascent market adds further risk, as a slowdown in quantum adoption could severely impact growth.
FAQ
The key risks are: (1) Financial risk: cash burn of -$424.76M in FCF, requiring continuous dilution; (2) Competitive risk: competition from IBM and Alphabet, which have more resources; (3) Valuation risk: PS ratio of 96.75x leaves little room for error; (4) Macro risk: beta of 3.301 makes the stock highly sensitive to market downturns. The most severe risk is a combination of these factors leading to a drop to the 52-week low of $25.89, a -42% loss from current levels.
The 12-month forecast is uncertain, with a base case probability of 50% targeting $50-$70, aligning with the analyst average of $67.68. The bull case (25% probability) targets $70-$100, driven by accelerated growth and government support. The bear case (25% probability) targets $25-$45, if growth disappoints and cash burn worsens. The most likely scenario is the base case, assuming revenue growth stabilizes and the company continues to secure funding.
IONQ is significantly overvalued based on traditional metrics. The trailing PS ratio of 96.75x is extremely high, though it is near the low end of its 5-year range of 127x to 8591x, suggesting a relative de-rating. The EV/Sales ratio of 55.87x also indicates a premium valuation. The market is pricing in massive future growth, expecting the company to become a dominant player in quantum computing. If growth decelerates further, the stock could face a severe correction. However, if the company delivers on its potential, the valuation could be justified.
IONQ is a high-risk, high-reward stock. With a Strong Buy consensus and an average target price of $67.68, analysts see 50.9% upside from the current price of $44.86. However, the stock trades at 96.75x trailing sales, and the company is deeply unprofitable, with an operating loss of $271.5M in Q1 2026. The biggest downside risk is a continued cash burn and dilution, which could lead to a drop to the 52-week low of $25.89. For aggressive investors with a long-term horizon and high risk tolerance, IONQ could be a good buy, but it is not suitable for conservative investors.
IONQ is more suitable for long-term investment, given its early-stage nature and high volatility. The stock's beta of 3.301 makes it prone to large swings, which is risky for short-term traders. The company is investing heavily in R&D, with the potential for significant returns over a 5-10 year horizon if quantum computing becomes mainstream. However, the risk of dilution and competition is high. A minimum holding period of 5 years is recommended to allow the technology to mature and the company to potentially achieve profitability.